NASARIX achieves positive biological safety resultsShares of Polyrizon Ltd. (NASDAQ:PLRZ) gained 10% on Friday after the ...

U.S. Medical Device Testing Services Market to Reach USD 7.05 Billion by 2035 at a 10.16% CAGR, While Europe Benefits from ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services. NEW YORK, NY, UNITED STATES, January 26, 2026 ...

Polyrizon Ltd. (NASDAQ: PLRZ) shares gathered steam to begin Thursday trading. The development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced ...

In the biocompatibility assessment of medical devices, two of the primary points of consideration are how long a device contacts the body and what type of tissue is contacted. Recently, FDA and the ...

New machine learning framework predicts promising nucleoside hydrogels before they are synthesized and tested in the ...

But you’ll need to be careful about which rubbers you buy, because more than 200,000 counterfeit condoms are being ...

Computational Modelling and Simulation (CM&S) is a powerful tool. When applied well, with the right questions and inputs, it ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

On 1 June 2026, the European Commission published a communication setting out a roadmap to phase out animal testing for ...

Periodontitis is one of the most common chronic inflammatory diseases worldwide and a leading cause of tooth loss in adults.